NSP vs. NBIX
Compare and contrast key facts about Insperity, Inc. (NSP) and Neurocrine Biosciences, Inc. (NBIX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NSP or NBIX.
Correlation
The correlation between NSP and NBIX is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NSP vs. NBIX - Performance Comparison
Key characteristics
NSP:
-0.94
NBIX:
0.38
NSP:
-1.22
NBIX:
0.70
NSP:
0.83
NBIX:
1.11
NSP:
-0.75
NBIX:
0.46
NSP:
-1.58
NBIX:
1.02
NSP:
20.50%
NBIX:
12.33%
NSP:
34.47%
NBIX:
33.34%
NSP:
-95.37%
NBIX:
-97.21%
NSP:
-40.03%
NBIX:
-11.58%
Fundamentals
NSP:
$2.99B
NBIX:
$13.84B
NSP:
$3.16
NBIX:
$3.75
NSP:
25.29
NBIX:
36.45
NSP:
1.42
NBIX:
0.32
NSP:
$6.55B
NBIX:
$2.24B
NSP:
$1.05B
NBIX:
$2.20B
NSP:
$235.05M
NBIX:
$614.00M
Returns By Period
In the year-to-date period, NSP achieves a -33.36% return, which is significantly lower than NBIX's 2.78% return. Over the past 10 years, NSP has underperformed NBIX with an annualized return of 18.47%, while NBIX has yielded a comparatively higher 20.40% annualized return.
NSP
-33.36%
4.78%
-18.26%
-32.81%
-0.36%
18.47%
NBIX
2.78%
9.84%
0.63%
11.77%
4.29%
20.40%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NSP vs. NBIX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Insperity, Inc. (NSP) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NSP vs. NBIX - Dividend Comparison
NSP's dividend yield for the trailing twelve months is around 3.11%, while NBIX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSP Insperity, Inc. | 3.11% | 1.90% | 1.77% | 3.18% | 1.97% | 1.39% | 0.86% | 2.75% | 1.37% | 1.77% | 8.08% | 1.88% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
NSP vs. NBIX - Drawdown Comparison
The maximum NSP drawdown since its inception was -95.37%, roughly equal to the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for NSP and NBIX. For additional features, visit the drawdowns tool.
Volatility
NSP vs. NBIX - Volatility Comparison
Insperity, Inc. (NSP) has a higher volatility of 10.89% compared to Neurocrine Biosciences, Inc. (NBIX) at 6.65%. This indicates that NSP's price experiences larger fluctuations and is considered to be riskier than NBIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NSP vs. NBIX - Financials Comparison
This section allows you to compare key financial metrics between Insperity, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities